8-KThe WireRed Alert
Executive Change · Reg FD Disclosure
Filed Dec 18, 2025 · 6mo ago · Accession 0001104659-25-122553
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing text
View original ↗UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 16, 2025
Owens & Minor, Inc .
(Exact name of registrant as specified in its charter)
Virginia
001-09810
54-1701843
(State or other jurisdiction of
(Commission
(I.R.S. Employer
incorporation or organization)
File Number)
Identification No.)
10900 Nuckols Road, Suite 400 ,
Glen Allen , Virginia
23060
(Address of principal executive
offices)
(Zip Code)
Post Office Box 27626,
Richmond, Virginia
23261-7626
(Mailing address of principal
executive offices)
(Zip Code)
Registrant’s telephone number, including area code (804) 723-7000
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $2 par value per share
OMI
New York Stock Exchange
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On December 16, 2025, the board of directors of Owens & Minor, Inc. (the “Company”) approved an amendment (the “Amendment”) to the Owens & Minor, Inc. Executive Deferred Compensation and Retirement Plan (the “EDCRP”), to freeze participation and all contributions under the EDCRP for all participants, effective as of January 1, 2026.
The foregoing description of the Amendment is only a summary and is qualified in its entirety by the Amendment, a copy of which will be filed with the Company’s Annual Report on Form 10-K for the year ending December 31, 2025.
Item 7.01. Regulation FD Disclosure.
On December 18, 2025, the Company issued a press release announcing that the Company will be changing its name to Accendra Health, Inc. and that the Company’s New York Stock Exchange ticker symbol will change to “ACH.” It is currently anticipated that the name change will be effective on or about December 31, 2025 and trading under the new name and symbol will begin on or about January 2, 2026. The Company is furnishing the press release attached hereto as Exhibit 99.1 pursuant to Item 7.01 of Form 8-K.
In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01.
Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Number
Exhibit Title or Description
99.1
Press Release of the Company, dated December 18, 2025 (furnished pursuant to Item 7.01).
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
OWENS & MINOR, INC.
Date: December 18, 2025
By:
/s/ Heath H. Galloway
Name:
Heath H. Galloway
Title:
Executive Vice President, General Counsel and Corporate Secretary
Filing details
- Company
- ACCENDRA HEALTH INC/VA/
- Ticker
- ACH
- CIK
- 75252
- Form type
- 8-K
- Filing date
- Dec 18, 2025
- Report date
- Dec 16, 2025
- Document
- omi-20251216x8k.htm
- Size
- 182 KB